-
Ferring presents phase III data for a controlled release misoprostol vaginal delivery system for labour induction at the First European Congress on Intrapartum Care
-Data from the EXPEDITE study presented today at the First European Congress on Intrapartum Care (ECIC) demonstrated…
0 -
Ferring Pharmaceuticals begins phase III trials of elobixibat, new compound with novel mechanism of action for chronic idiopathic constipation
-Ferring Pharmaceuticals today announced it has initiated enrolment of patients in two phase III clinical trials…
-
Ferring to Present Safety Analysis for FIRMAGON® (degarelix) at the American Urological Association Annual Meeting
-The following data will be presented at the annual meeting of the American Urological Association (AUA) in San Diego…
Archive for May, 2013
2013 > May